This opportunity is no longer accepting applications.
grant PAR-25-107

Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)

The National Cancer Institute is offering grants for research involving bacteria, bacteriophages, or non-oncolytic viruses to study their interactions with tumors and the immune system. The aim is to explore their clinical potential for cancer imaging, therapeutics, or diagnostics. Projects may focus on using these microorganisms as anti-tumor agents, immunity activators, or delivery vehicles …

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to study the underlying mechanisms of the complex interactio…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute

Dates

Opportunity Released: November 7, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.